AUPH,Aurinia Pharmaceuticals Inc. | Healthcare

Healthcare

AUPH

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Aurinia Pharmaceuticals Inc.AUPH

USD

-0.15 (-1.89%)

Jun 20, 2025, 4:00 PM - At close

USD

-0.01 (-0.13%)

Jun 20, 2025, 7:02 PM EDT - Until the end

The complete list of US stocks

MAX

Overview >

Market Cap

1.05B

Revenue (ttm)

247.30M

Net Income (ttm)

39.85M

Shares Out

135.10M

EPS (ttm)

0.27

PE Ratio

29.21

Forward PE

12.35

Dividend

n/a

Ex-Dividend Date

n/a

Volume

1,196,238

Open

7.97

Previous Close

7.92

Day's Range

7.74 - 7.98

52-Week Range

5.20 - 10.67

Beta

1.16

Analysts

Strong Buy

Price Target

11.50 (+48.01%)

Earnings Date

Jul 31, 2025

Description >

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States.

The company also offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

Latest News >

USDCHF is between the hammer and anvil -Analysis-30-04-2025

May 25, 2025

USDCHF declined in its last intraday trading, with the trading alongside a main bearish trend line on the short- term basis, and the negative signals begin to appear on the (RSI), after its succeed to offload the oversold conditions in its previous trading, reinforcing the negative pressures on the price, on the other hand, the positive support that comes from...

USDCHF price gets ready to break a critical support -Analysis-19-05-2025

May 25, 2025

The (USDCHF) declined in its last intraday trading, after it succeeded in offloading some of its oversold conditions on the (RSI), after gaining some positive momentum due to the stability of the critical support level at 0.8320, but it returned to decline after reaching the resistance of the EMA50, accompanied by testing a minor bearish bias line on the short-term...

USDCHF suffers from negative pressures -Analysis-21-05-2025

May 25, 2025

The (USDCHF) price continued the decline its last intraday trading, by a continuous negative pressure due to its trading below its EMA50, to break a bullish correctional trend line on the short-term basis, which increases the negative pressures around the pair, especially with the emergence of the negative signals on the (RSI), despite reaching oversold levels. Do you need help...

USDCHF is under intensified negative pressure-Analysis-05-05-2025

May 25, 2025

(USDCHF) price declined in its recent intraday trading, confirming breaking the bullish correctional trendline on the short-term basis, accompanied by surpassing the support of its EMA50, the intensive negative pressures increase the possibility of the decline, especially with the emergence of negative overlapping signal on the (RSI), after offloading the oversold conditions. Do you need help in trading decisions? Do...